Fate Therapeutics

In News

FATE Stock Jumps 6% As FDA Greenlights Moving Cell Therapy To Clinical Trials - Stocktwits

Stocktwits - Oct 17, 2026

Fate Therapeutics, Inc. (FATE) stock price, news, quote and history - Yahoo Finance Singapore

Yahoo Finance Singapore - Oct 13, 2026

Fate Therapeutics, Inc. Stock 12‑Month Price Target Cut to $6.07, Implies 215% Upside - TradingView

TradingView - Oct 16, 2026

Fate Therapeutics Appoints Jamie Harrell as Senior Vice - GlobeNewswire

GlobeNewswire - Oct 12, 2026

Three therapies Harrell helped commercialize each topped $1B a year in U.S. sales. He joins Fate Therapeutics. - Stock Titan

Stock Titan - Oct 12, 2026

Fate Therapeutics appoints Jamie Harrell to lead commercial strategy - Investing.com

Investing.com - Oct 12, 2026

We're Keeping An Eye On Fate Therapeutics' (NASDAQ:FATE) Cash Burn Rate - Simply Wall Street

Simply Wall Street - Oct 12, 2026

Fate Therapeutics stock fell 7.01 percent on October 16, 2026 - ad-hoc-news.de

ad-hoc-news.de - Oct 17, 2026

Fate Therapeutics begins Phase II trial of FT819 for lupus nephritis - Clinical Trials Arena

Clinical Trials Arena - Aug 17, 2026

CIRM Awards Fate Therapeutics $15M for FT819 Lupus Nephritis Trial - The Clinical Trial Vanguard

The Clinical Trial Vanguard - Sep 29, 2026

Fate Therapeutics appoints Jamie Harrell to lead commercialization - Investing.com

Investing.com - Oct 12, 2026

Fate Therapeutics (FATE) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Yahoo Finance - Aug 13, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment